Xeris Biopharma Holdings (XERS) Change in Receivables (2020 - 2026)
Xeris Biopharma Holdings (XERS) reported Change in Receivables of $1.81 million for Q2 2026, down 73.1% from $6.72 million a year earlier and down 65.5% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Change in Receivables (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Xeris Biopharma Holdings' Change in Receivables came in at $5.06 million, down 52.3% year-over-year; for FY2025, it came in at $10.64 million, up 773.2% from FY2024.
- Change in Receivables has a five-year compound annual growth rate of 37.3% (FY2020 to FY2025).
- By year, Change in Receivables came in at $1.22 million in FY2024 (-85.4%), $8.37 million in FY2023 (-37.4%), $13.37 million in FY2022 (+114.4%) and $6.24 million in FY2021 (+185.8%).
- Five-year quarterly Change in Receivables spans a low of -$6.77 million in Q4 2023 and a high of $15.74 million in Q3 2023.
- The high point for year-over-year Change in Receivables in five years was Q3 2023 (growth of 793.4%); the low point was Q1 2023 (a decline of 99.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.25 million (Q1 2026), -$2.7 million (Q4 2025) and $703,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Xeris Biopharma Holdings | 1.66 Bn | 1.22 Bn | 79.59 Mn | 1.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.81 Mn |
| Mar 31, 2026 | 5.25 Mn |
| Dec 31, 2025 | -2.70 Mn |
| Sep 30, 2025 | 703,000.00 |
| Jun 30, 2025 | 6.72 Mn |
| Mar 31, 2025 | 5.92 Mn |
| Dec 31, 2024 | -723,000.00 |
| Sep 30, 2024 | -1.30 Mn |
| Jun 30, 2024 | 5.03 Mn |
| Mar 31, 2024 | -1.78 Mn |
| Dec 31, 2023 | -6.77 Mn |
| Sep 30, 2023 | 15.74 Mn |
| Jun 30, 2023 | -635,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2022 | 3.31 Mn |
| Sep 30, 2022 | 1.76 Mn |
| Jun 30, 2022 | 2.37 Mn |
| Mar 31, 2022 | 5.93 Mn |
| Dec 31, 2021 | -449,000.00 |
| Sep 30, 2021 | 1.27 Mn |
API Access
Xeris Biopharma Holdings Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();